At Rophevac, our Research & Development is at the heart of everything we do. We are committed to pioneering innovative genomic solutions that transform healthcare and improve patient outcomes across India and globally.
Pioneering breakthrough technologies in genomics and molecular biology
Comprehensive genomic analysis using whole genome sequencing, exome sequencing, and targeted sequencing approaches.
Learn MoreCell-type specific analysis revealing tumor heterogeneity, immune profiling, and disease mechanisms at single-cell resolution.
Learn MoreDNA methylation and chromatin accessibility analysis for cancer classification, biomarker discovery, and gene regulation studies.
Learn MoreProtein expression profiling and metabolic pathway analysis for functional validation and biomarker discovery.
Learn MoreNon-invasive cancer detection and monitoring using circulating tumor DNA, CTCs, and extracellular vesicles.
Learn MoreCRISPR/Cas9 technology, high-throughput screening, and organoid models for target validation and disease modeling.
Learn MoreGene expression and protein localization in tissue context for tumor microenvironment and disease progression studies.
Learn MoreRophevac's R&D operations are focused on advancing genetic testing technologies, developing precision medicine solutions, and creating next-generation diagnostic tools that enable early disease detection, accurate diagnosis, and personalized treatment strategies.
Scientific Publications
Patents Filed
Tests Performed Annually
Revenue in R&D